Atlas Trials

Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)

Clinical trial NCT00639626 · TERMINATED

Trial details

NCT number
NCT00639626
Sponsor
Nationwide Children's Hospital
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cystic Fibrosis Related Diabetes
Start date
2008-08-01
Primary completion
2010-05-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.